MedTrace Logo

Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis

NCT05271773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2025-12-02

No results posted yet for this study

Summary

This study is therefore postulated as a clear alternative that evaluates patients´quality of life, and recognises fecal calprotectin as an inflammatory marker.

Longitudinal, prospective, multi-center cohort study to measure the impact that the therapeutic attitude (treatment intensification/de-intensification o escalation/de-escalation) has on the quality of life of patients with UC given a colonoscopy revealing mucosal healing (Mayo 0, Mayo 1); considering as treatment intensification/de-intensification a dose increase or decrease on the same line of treatment, and escalation/de-escalation if there is a change to a new line of treatment.

Conditions

  • IBD-Inflammatory Bowel Disease
  • UC - Ulcerative Colitis

Sponsors & Collaborators

  • Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

    lead OTHER

Principal Investigators

  • GETECCU GETECCU · Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2024-11-30
Completion
2025-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05271773 on ClinicalTrials.gov